共 50 条
- [23] Assessing real world dose adjustment in patients switching from intravenous immunoglobulin (IGIV) therapy to subcutaneous immunoglobulin (IGSC) 20%. PHARMACOTHERAPY, 2014, 34 (10): : E222 - E222
- [24] Impact of therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients receiving HAART or IL-2 FASEB JOURNAL, 1999, 13 (04): : A294 - A294